SOLIPHEN 15 mg tablet for dogs
SOLIPHEN 15 mg tablet for dogs
Authorised
- Phenobarbital
Product identification
Medicine name:
SOLIPHEN 15 mg tablet for dogs
SOLIPHEN 15 mg Tabletten für Hunde
Active substance:
- Phenobarbital
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Phenobarbital15.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN03AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Available in:
-
Germany
Package description:
- (ID2) 96 Tablet: Box (Cardboard) with 8 Blister (PolyVinyl Chloride) each with 12 Tablet, closed with Foil (Aluminium)
- (ID1) 60 Tablet: Box (Cardboard) with 5 Blister (PolyVinyl Chloride) each with 12 Tablet, closed with Foil (Aluminium)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Domes Pharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Europeenne De Pharmacotechnie Europhartech
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- V7004476.00.00
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0305/002
Concerned member states:
-
Austria
-
Belgium
-
France
-
Italy
-
Luxembourg
-
Netherlands
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet